BUSINESS● LOW2h ago · Sep 10, 2026, 1:41 PM
Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks
Yahoo Finance · global
A major shareholder of Novartis is advocating for changes to the company's board following recent drug trial failures. This indicates significant corporate governance pressure within the pharmaceutical giant.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowIn the DRC, the Makoko deposit is becoming central to Ivanhoe Mines' plansJeune AfriqueBUSINESS37m agoCrude inventory falls by 0.4M barrels for the week ended September 4 – EIASeeking Alpha TechBUSINESS38m agoSpaceX shares higher as data center overhaul, budding UK defense deal in focusYahoo FinanceBUSINESS38m agoFirstRand Limited reports FY resultsSeeking Alpha Tech